Tech execs are donating millions to make MDMA a legal treatment for PTSD, continuing Silicon Valley's longtime love-affair with psychedelics

Paul Morigi/CNBC/NBCU Photo Bank/NBCUniversal via Getty Images

• A group of Silicon Valley and Wall Street executives have donated $30 million towards an initiative to research the therapeutic applications of MDMA, a psychedelic drug as an ingredient in ecstasy. 
• The research aims to seek approval from the FDA for the use of MDMA to treat PSTD. 
• If successful, it would be the first ever psychedelic-assisted psychotherapy to earn FDA approval.
• Psychedelic research has long been tied to interest from Silicon Valley's elite. 
• Visit Business Insider's homepage for more stories.

A veritable who's who of Silicon Valley and Wall Street have donated $30 million to fund research exploring the therapeutic use of the psychedelic drug MDMA, according to a report released on Thursday. 

If successful, the research, which focuses on treating post-traumatic stress disorder, will make MDMA the first psychedelic-assisted psychotherapy to earn FDA approval.

See the rest of the story at Business Insider

NOW WATCH: How the Navy's largest hospital ship can help with the coronavirus

See Also:

• Here's what happens when two hurricanes collide
• The best espresso machines
• 20 US presidents who belonged to secret societies

SEE ALSO: Founders explain how microdosing on psychedelics has helped them spur new business ideas

READ MORE: Meet the top 9 startups raising millions to use psychedelics to treat depression, anxiety, and more

from Business Insider https://ift.tt/34kZN3i